Medipharm Labs Corp
TSX:LABS
Medipharm Labs Corp
TSX:LABS
Price:
0.07
CAD
-6.67%
Market Cap:
CA$29.7m
Balance Sheet
Balance Sheet Decomposition
Medipharm Labs Corp
Medipharm Labs Corp
Balance Sheet Decomposition is not available for
Medipharm Labs Corp
Medipharm Labs Corp
Balance Sheet
Medipharm Labs Corp
Medipharm Labs Corp
Currency: CAD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
8
|
39
|
20
|
34
|
24
|
18
|
12
|
|
| Cash Equivalents |
8
|
39
|
20
|
34
|
24
|
18
|
12
|
|
| Total Receivables |
6
|
28
|
34
|
17
|
13
|
6
|
8
|
|
| Accounts Receivables |
6
|
26
|
28
|
16
|
12
|
6
|
7
|
|
| Other Receivables |
0
|
1
|
6
|
1
|
1
|
0
|
1
|
|
| Inventory |
9
|
52
|
22
|
11
|
8
|
10
|
9
|
|
| Other Current Assets |
3
|
2
|
5
|
4
|
2
|
3
|
5
|
|
| Total Current Assets |
27
|
120
|
82
|
66
|
47
|
37
|
33
|
|
| PP&E Net |
14
|
42
|
34
|
26
|
18
|
25
|
19
|
|
| PP&E Gross |
14
|
42
|
34
|
26
|
18
|
25
|
19
|
|
| Accumulated Depreciation |
1
|
4
|
16
|
25
|
25
|
27
|
23
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
7
|
2
|
1
|
0
|
1
|
1
|
|
| Total Assets |
43
N/A
|
169
+295%
|
118
-30%
|
92
-22%
|
66
-29%
|
64
-2%
|
54
-16%
|
|
| Liabilities | ||||||||
| Accounts Payable |
8
|
19
|
6
|
3
|
4
|
2
|
4
|
|
| Accrued Liabilities |
1
|
3
|
9
|
4
|
4
|
5
|
4
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
6
|
2
|
8
|
0
|
0
|
2
|
0
|
|
| Other Current Liabilities |
0
|
5
|
2
|
2
|
2
|
2
|
1
|
|
| Total Current Liabilities |
15
|
29
|
24
|
9
|
10
|
11
|
10
|
|
| Long-Term Debt |
0
|
9
|
11
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
5
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
15
N/A
|
37
+147%
|
40
+7%
|
9
-77%
|
10
+3%
|
11
+15%
|
11
-4%
|
|
| Equity | ||||||||
| Common Stock |
34
|
123
|
139
|
191
|
191
|
200
|
201
|
|
| Retained Earnings |
6
|
9
|
60
|
107
|
135
|
147
|
158
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
28
N/A
|
132
+376%
|
78
-40%
|
83
+6%
|
56
-33%
|
53
-5%
|
43
-19%
|
|
| Total Liabilities & Equity |
43
N/A
|
169
+295%
|
118
-30%
|
92
-22%
|
66
-29%
|
64
-2%
|
54
-16%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
98
|
132
|
156
|
274
|
282
|
401
|
415
|
|
Switch to:
Switch to:
See Also
Discover More
